Dealing with runaway metastatic disease - ecancer
ecancer,
A new editorial paper was published inOncotarget'sVolume 15on July 12, 2024, entitled, How to deal with runaway metastatic…
A new editorial paper was published inOncotarget'sVolume 15on July 12, 2024, entitled, How to deal with runaway metastatic…
These findings indicate that renalase-1 is a potential antigen for TCR recognition in melanoma and could be considered as a…
A new editorial paper titled "How to deal with runaway metastatic disease?" has been published in Oncotarget.
More recently, in a large preclinical study using cancer cell lines and various mouse models of human melanomas, the…
BUFFALO, NY – August 7, 2024 – A new editorial paper was published in Oncotarget’s Volume 15 on July 12, 2024, entitled, “How…
BUFFALO, NY - August 7, 2024 – A new editorial paper was published in Oncotarget's Volume 15 on July 12, 2024, entitled, "How…
“Metastatic disease remains a major issue in daily practice in oncology because the outcome is still often fatal.” image…
Metastatic disease remains a major issue in daily practice in oncology because the outcome is still often fatal.